Unraveling resistance to CDK4/6 inhibitors in ovarian cancer
The Promising Horizon of Biomarker Discovery in Ovarian Cancer The relentless quest to conquer ovarian cancer, the leading cause of death among gynecological malignancies, is witnessing a potential breakthrough with biomarker discovery. Recent research highlights the significant role of TRIM4, an E3 ligase, as a key player in determining sensitivity to CDK4/6 inhibitors, an emerging … Read more